SCHEMBL24616775

SCHEMBL24616775

C=C/C(=C\C=C/C)C(=O)Oc1cccc2cccc(OC(=O)c3ccccc3)c12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.41
METAP2 P50579 1/20 0.41
METAP1 P53582 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
KMT2A Q03164 9/20 0.39
MAPT P10636 4/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
SLC6A3 Q01959 1/20 0.39
MEN1 O00255 4/20 0.38
HSD17B10 Q99714 2/20 0.38
JAK2 O60674 1/20 0.38
USP2 O75604 1/20 0.38
ESR1 P03372 1/20 0.38
GAA P10253 1/20 0.38
ALOX15 P16050 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
ESR2 Q92731 1/20 0.38
TDP1 Q9NUW8 4/20 0.37
CYP3A4 P08684 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19155593 0.78 TDP1 (0.31) KMT2AMAPTSMN1; SMN2SLC6A3MEN1
SCHEMBL12355077 0.77 KMT2A (0.61) LMNAMETAP2METAP1HDAC6KMT2A
SCHEMBL19650346 0.76 POLB (0.30) TDP1ATMPOLB
SCHEMBL21921326 0.75 ELANE (0.39) MAPTHSD17B10GAAALOX15TDP1
SCHEMBL20646376 0.73 KMT2A (0.44) LMNAMETAP2METAP1HDAC6KMT2A
SCHEMBL20922636 0.73 MAPT (0.43) LMNAMAPTSMN1; SMN2HSD17B10TDP1
SCHEMBL19642801 0.73 LMNA (0.54) LMNAMETAP2METAP1HDAC6KMT2A
SCHEMBL17502636 0.72 ESR1 (0.56) LMNAMETAP2METAP1HDAC6KMT2A
SCHEMBL19642843 0.70 LMNA (0.54) LMNAMETAP2METAP1HDAC6KMT2A
SCHEMBL19420680 0.70 AKT1 (0.46) LMNAMAPTSMN1; SMN2HSD17B10USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220220060-A1 CATALYST COMPOSITION FOR POLYOLEFIN POLYMERS W.R. GRACE & CO.-CONN (US) 2022-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220220060-A1 CATALYST COMPOSITION FOR POLYOLEFIN POLYMERS DNTT, TKT, APRT LMNA 2885/4885METAP2 648/4885METAP1 602/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.